Medicare Enrolled

Dr. Syed Zafar, M.D.

Hematology · Fort Myers, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
8260 GLADIOLUS DR, Fort Myers, FL 33908
2394375755
Registered in NPPES since 2007
NPI: 1811187909 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zafar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zafar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zafar

Dr. Syed Zafar is a hematology specialist in Fort Myers, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Zafar performed 371,813 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Zafar received a total of $79,891 from 80 pharmaceutical and/or device companies across 755 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zafar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 4% volume in FL $79,891 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 116003 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
371,813
Medicare services
Top 4% in FL for hematology
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Pembrolizumab injection (Keytruda) 71,200 $43 $137
Anti-nausea injection (aprepitant) 45,630 $1 $5
Filgrastim injection (Zarxio) for white blood cells
An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram.
40,920 $0 $2
Nivolumab injection (Opdivo) 27,080 $24 $72
Oxaliplatin chemotherapy injection
This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg.
24,900 $0 $12
Daratumumab injection (Darzalex)
An injection containing daratumumab and hyaluronidase-fihj administered under the skin.
18,360 $38 $110
Iron sucrose injection (Venofer)
An injection of iron sucrose used to replenish iron levels in the body.
17,600 $0 $5
Iron infusion (Feraheme)
An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis.
12,750 $0 $4
Paclitaxel chemotherapy injection 12,270 $0 $2
Filgrastim injection, 1 microgram
An injection of filgrastim, a medication that stimulates the production of white blood cells. This code specifically covers the brand-name drug and excludes biosimilar versions.
11,100 $1 $3
Denosumab injection (Prolia/Xgeva) 10,740 $19 $51
Azacitidine chemotherapy injection
An injection of the medication azacitidine, measured at 1 mg per unit.
9,200 $0 $4
Epoetin alfa injection (Procrit) for anemia
An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis.
8,500 $6 $23
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
7,370 $0 $3
Injection, docetaxel, 1 mg 5,866 $0 $7
Immune globulin infusion (Gammagard)
An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg.
5,312 $36 $108
Anti-nausea injection (Aloxi/palonosetron) 4,640 $1 $28
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
3,797 $8 $29
Bortezomib injection, 0.1 mg
Administration of a 0.1 mg dose of bortezomib medication via injection.
3,417 $4 $113
Injection, leucovorin calcium, per 50 mg 3,101 $3 $12
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
2,930 $8 $9
Pemetrexed chemotherapy injection, 10 mg
This procedure involves the administration of a 10 mg dose of pemetrexed, a chemotherapy medication, via injection.
2,657 $56 $202
Eflapegrastim injection, 0.1 mg
An injection of eflapegrastim-xnst administered at a dose of 0.1 mg.
2,508 $26 $116
Fluorouracil injection, 500 mg
Administration of a 500 mg dose of fluorouracil medication via injection.
1,917 $2 $7
Anti-nausea injection (ondansetron/Zofran) 1,720 $0 $9
Injection, atropine sulfate, 0.01 mg 1,480 $0 $1
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
1,456 $12 $61
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,453 $100 $339
Injection, octreotide, depot form for intramuscular injection, 1 mg 1,370 $161 $515
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
1,196 $102 $378
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
976 $11 $69
Etoposide chemotherapy injection
Administration of etoposide, a chemotherapy medication, via injection. The dose specified is 10 mg.
932 $1 $18
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
819 $67 $239
Carboplatin chemotherapy injection, 50 mg
Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection.
667 $2 $41
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
428 $22 $84
Cisplatin chemotherapy injection, 10 mg
Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection.
420 $2 $13
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
392 $50 $189
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
383 $2 $7
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
378 $10 $42
Magnesium sulfate injection, per 500 mg
An injection of magnesium sulfate administered in 500 mg increments.
308 $1 $2
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
302 $1 $3
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
299 $1 $6
Intravenous hydration infusion, 31-60 minutes
Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes.
278 $25 $156
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
258 $51 $178
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
257 $22 $79
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
243 $7 $69
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
230 $58 $206
IV chemotherapy initiation with community continuation
Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living.
230 $133 $637
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
207 $16 $56
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
178 $17 $59
Leuprolide acetate (for depot suspension), 7.5 mg 137 $132 $562
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
127 $26 $89
Concurrent intravenous infusion
Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given.
118 $16 $56
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
102 $131 $453
Intravenous push injection of new drug or substance
A healthcare provider injects a new medication or substance directly into a vein using a push technique.
98 $45 $170
Normal saline infusion, 500 ml
Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution.
93 $1 $7
Intravenous chemotherapy injection
Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein.
82 $81 $303
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
79 $30 $156
Automated red blood cell count
An automated laboratory test that measures the number of red blood cells in a blood sample.
71 $4 $10
New patient office visit, complex (60-74 min) 68 $169 $585
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
63 $2 $8
Methylprednisolone injection, up to 40 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg.
59 $3 $11
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
44 $65 $192
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
32 $143 $474
Automated red blood cell count with calculations
A blood test that automatically counts red blood cells and performs additional calculations to assess blood health.
15 $5 $20
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
5.8% high complexity
91.5% medium
2.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$79,891
Total received (2018-2024)
Avg $11,413/year across 7 years
Top 7% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
755
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$8,592
2023
$9,428
2022
$21,599
2021
$2,721
2020
$2,878
2019
$20,534
2018
$14,140

Payments by company (2024)

GlaxoSmithKline, LLC.
$2,566
TAIHO ONCOLOGY, INC.
$1,934
BeiGene USA, Inc.
$1,643
AstraZeneca Pharmaceuticals LP
$1,388
Janssen Biotech, Inc.
$243
E.R. Squibb & Sons, L.L.C.
$188
Takeda Pharmaceuticals U.S.A., Inc.
$130
PFIZER INC.
$109
Gilead Sciences, Inc.
$104
Intera Oncology, Inc
$69
Daiichi Sankyo Inc.
$53
Astellas Pharma US Inc
$40
ARRAY BIOPHARMA INC
$37
Merck Sharp & Dohme LLC
$26
Exelixis Inc.
$19
ABBVIE INC.
$16
Novartis Pharmaceuticals Corporation
$15
Eisai Inc.
$14
Top 3 companies account for 71.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$13,849
Seagen Inc.
$8,714
Janssen Biotech, Inc.
$6,019
E.R. Squibb & Sons, L.L.C.
$5,219
GlaxoSmithKline, LLC.
$4,901
BeiGene USA, Inc.
$4,063
Verastem, Inc.
$3,572
Bayer HealthCare Pharmaceuticals Inc.
$3,480
Celgene Corporation
$3,349
Seattle Genetics, Inc.
$3,061
Karyopharm Therapeutics Inc.
$2,460
NOVARTIS PHARMACEUTICALS CORPORATION
$2,160
Merck Sharp & Dohme LLC
$2,124
Taiho Oncology, Inc.
$1,987
TAIHO ONCOLOGY, INC.
$1,934
MorphoSys, US Inc.
$1,845
BeiGene, Ltd.
$1,512
Novartis Pharmaceuticals Corporation
$988
Bayer Healthcare Pharmaceuticals Inc.
$866
Merck Sharp & Dohme Corporation
$768
PFIZER INC.
$754
ABBVIE INC.
$680
Epizyme, Inc.,
$549
Incyte Corporation
$509
Genentech USA, Inc.
$483
Gilead Sciences, Inc.
$256
Agios Pharmaceuticals, Inc.
$207
Daiichi Sankyo Inc.
$191
Takeda Pharmaceuticals U.S.A., Inc.
$190
Lilly USA, LLC
$187
Adaptive Biotechnologies Corporation
$182
Spectrum Pharmaceuticals Inc.
$179
Exelixis Inc.
$175
GENZYME CORPORATION
$171
Amgen Inc.
$157
NanoString Technologies, Inc.
$125
Regeneron Healthcare Solutions, Inc.
$122
Janssen Pharmaceuticals, Inc
$116
MENARINI SILICON BIOSYSTEMS, INC.
$115
Deciphera Pharmaceuticals Inc.
$109
JAZZ PHARMACEUTICALS INC.
$101
Intuitive Surgical, Inc.
$96
Eisai Inc.
$95
ACELL, INC.
$94
Ipsen Biopharmaceuticals, Inc
$93
Pharmacyclics LLC, An AbbVie Company
$86
Array BioPharma Inc.
$85
ARRAY BIOPHARMA INC
$85
Astellas Pharma US Inc
$74
Intera Oncology, Inc
$69
EMD Serono, Inc.
$57
AbbVie, Inc.
$53
EUSA Pharma (US) LLC
$48
Rigel Pharmaceuticals, Inc.
$40
CSL Behring
$38
AbbVie Inc.
$35
Alnylam Pharmaceuticals Inc.
$30
Dendreon Pharmaceuticals LLC
$25
GE HEALTHCARE
$25
Dexcom, Inc.
$24
PharmaEssentia USA Corporation
$23
Clovis Oncology, Inc.
$23
Pharmacyclics LLC, an AbbVie Company
$23
Immunomedics, Inc.
$22
Kite Pharma, Inc.
$20
Sirtex Medical Inc
$19
TESARO, Inc.
$18
TerSera Therapeutics LLC
$17
SOBI, INC
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
CTI BioPharma Corp.
$15
Helsinn Therapeutics (U.S.), Inc.
$13
Global Blood Therapeutics, Inc.
$13
Sun Pharmaceutical Industries Inc.
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
EISAI INC.
$12
ADC Therapeutics America, Inc.
$12
Secura Bio, Inc.
$11
Fortovia Therapeutics, Inc.
$5
Veracyte, Inc.
$4
Top 3 companies account for 35.8% of all-time payments
Associated products mentioned in payments ›
6 · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · Abraxane · Alecensa · Aliqopa · Avastin · BESREMI · BEVESPI AEROSPHERE · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CAR-T · CEREZYME · CYRAMZA · Cabometyx · Cellsearch · Copiktra · Creon · DARZALEX · Da Vinci Surgical System · Dexcom G6 Transmitter · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Erleada · FARXIGA · FRUZAQLA · Farydak · GAUCHER-DISEASE · GAZYVA · GILOTRIF · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INTERA · INVOKANA · Idelvion · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · NINLARO · Neulasta · Nplate · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · PADCEV · PIQRAY · PROMACTA · PROSIGNA ASSAY · PROVENGE · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · Revlimid · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SPRYCEL · SUTENT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Trodelvy · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XIFAXAN · XPOVIO · XTANDI · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zevalin · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology specialist in Fort Myers?
Compare hematologists in the Fort Myers area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists in nearby ZIP areas
15
County median income
$73,099
Nearest hospital to ZIP centroid (approximate)
PARK ROYAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Zafar is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Zafar experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Zafar performed 71,200 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Zafar receive payments from pharmaceutical companies?
Yes. Dr. Zafar received a total of $79,891 from 80 companies across 755 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zafar's costs compare to other hematologists in Fort Myers?
Dr. Zafar's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zafar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →